Literature DB >> 12763035

Intracellular delivery of glutathione S-transferase into mammalian cells.

Shigeyuki Namiki1, Taichiro Tomida, Mao Tanabe, Masamitsu Iino, Kenzo Hirose.   

Abstract

Protein transduction domains (PTDs) derived from human immunodeficiency virus Tat protein and herpes simplex virus VP22 protein are useful for the delivery of non-membrane-permeating polar or large molecules into living cells. In the course of our study aiming at evaluating PTD, we unexpectedly found that the fluorescent-dye-labeled glutathione S-transferase (GST) from Schistosoma japonicum without known PTDs was delivered into COS7 cells. The intracellular transduction of GST was also observed in HeLa, NIH3T3, and PC12 cells, as well as in hippocampal primary neurons, indicating that a wide range of cell types is permissive for GST transduction. Furthermore, we showed that the immunosuppressive peptide VIVIT fused with GST successfully inhibits NFAT activation. These results suggest that GST is a novel PTD which may be useful in the intracellular delivery of biologically active molecules, such as small-molecule drugs, bioactive peptides, or proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763035     DOI: 10.1016/s0006-291x(03)00807-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Distinct roles of calcineurin-nuclear factor of activated T-cells and protein kinase A-cAMP response element-binding protein signaling in presynaptic differentiation.

Authors:  Tomoyuki Yoshida; Masayoshi Mishina
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

2.  Membrane transducing activity of recombinant Hoxc8 protein and its possible application as a gene delivery vector.

Authors:  Eun Shin Kim; Myengmo Kang; Hyoung Woo Park; Myoung Hee Kim
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

3.  Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity.

Authors:  Jamie E Rayahin; Jason S Buhrman; Richard A Gemeinhart
Journal:  Eur J Pharm Sci       Date:  2014-09-21       Impact factor: 4.384

4.  A structural basis for cellular uptake of GST-fold proteins.

Authors:  Melanie J Morris; Dan Liu; Llara M Weaver; Philip G Board; Marco G Casarotto
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

5.  Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei.

Authors:  Masakiyo Sakaguchi; Takamasa Nukui; Hiroyuki Sonegawa; Hitoshi Murata; Junichiro Futami; Hidenori Yamada; Nam-ho Huh
Journal:  Nucleic Acids Res       Date:  2005-05-26       Impact factor: 16.971

6.  ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma.

Authors:  Ji-Ye Kim; Entaz Bahar; Jung-Yun Lee; Sunhee Chang; Se Hoon Kim; Eun Young Park; Sung-Im Do; Hyonok Yoon; Hyun-Soo Kim
Journal:  Cell Death Dis       Date:  2022-03-15       Impact factor: 8.469

7.  Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.

Authors:  Stephanie Kreis; Demetra Philippidou; Christiane Margue; Catherine Rolvering; Claude Haan; Laure Dumoutier; Jean-Christophe Renauld; Iris Behrmann
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

8.  NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network.

Authors:  Eleonora Mammarella; Carlotta Zampieri; Emanuele Panatta; Gerry Melino; Ivano Amelio
Journal:  Biol Direct       Date:  2021-08-04       Impact factor: 4.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.